Int. J. Mol. Sci. 2011, 12(2), 983-1008; doi:10.3390/ijms12020983
Review

Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer

1email and 2,* email
Received: 15 December 2010; in revised form: 19 January 2011 / Accepted: 28 January 2011 / Published: 31 January 2011
(This article belongs to the Special Issue Cancer Molecules in Ovarian Cancer)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The involvement of epigenetic aberrations in the development and progression of tumors is now well established. However, most studies have focused on the epigenetic inactivation of tumor suppressor genes during tumorigenesis and little is known about the epigenetic activation of cancer-associated genes, except for the DNA hypomethylation of some genes. Recently, we reported that the overexpression of cancer-promoting genes in ovarian cancer is associated with the loss of repressive histone modifications. This discovery suggested that epigenetic derepression may contribute to ovarian tumorigenesis by constituting a possible mechanism for the overexpression of oncogenes or cancer-promoting genes in tumors. The emerging importance of epigenetic aberrations in tumor initiation and in the regulation of cancer-initiating cells, suggests that epigenetically regulated genes may be promising therapeutic targets and biomarkers. Given that the current challenges in ovarian cancer include the identification of biomarkers for early cancer detection and the discovery of novel therapeutic targets for patients with recurrent malignancies undergoing chemotherapy, understanding the epigenetic changes that occur in ovarian cancer is crucial. This review looks at epigenetic mechanisms involved in the regulation of cancer-associated genes, including the contribution of epigenetic derepression to the activation of cancer-associated genes in ovarian cancer. In addition, possible epigenetic therapies targeting epigenetically dysregulated genes are discussed. A better understanding of the epigenetic changes in ovarian cancer will contribute to the improvement of patient outcomes.
Keywords: ovarian cancer; epigenetic derepression; DNA methylation; histone modification; miRNA; epigenetic therapy; chemoresistance; cancer-initiating cells
PDF Full-text Download PDF Full-Text [621 KB, uploaded 19 June 2014 03:30 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Kwon, M.J.; Shin, Y.K. Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer. Int. J. Mol. Sci. 2011, 12, 983-1008.

AMA Style

Kwon MJ, Shin YK. Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer. International Journal of Molecular Sciences. 2011; 12(2):983-1008.

Chicago/Turabian Style

Kwon, Mi Jeong; Shin, Young Kee. 2011. "Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer." Int. J. Mol. Sci. 12, no. 2: 983-1008.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert